The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 601–700 of 1,007
Frailty and clinical benefits with lung transplantation
Rozenberg, D., Mathur, S., Wickerson, L. M., Chowdhury, N., & Singer, L. G. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.06.005 · Cited by 72
The course of persistent airflow limitation in subjects with and without asthma
Guerra, S., Sherrill, D. L., Kurzius-Spencer, M., Venker, C., Halonen, M., Quan, S. F., & Martinez, F. D. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.011 · Cited by 66
“a Modified Medical Research Council dyspnea scale.(33) b Wheal at least 2 mm larger than the control wheal for at least one tested allergen in at least one of the three test surveys.”
Factors determining the quality of life of patients with COPD in primary care
Miravitlles, M., Molina, J., Naberán, K., Cots, J. M., Ros, F., & Llor, C. (2007) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465807086097 · Cited by 67
Diagnosis and treatment considerations for women with COPD
Côté, C., & Chapman, K. R. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01987.x · Cited by 74
Validation of clinical control in COPD as a new tool for optimizing treatment
Soler‐Cataluña, J. J., Marzo, M., Catalán, P., Miralles, C., Navarrete, B. A., & Miravitlles, M. (2018) · International Journal of COPD · doi:10.2147/copd.s178149 · Cited by 67
Ambrosino, N., & Fracchia, C. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2019.04.002 · Cited by 67
Alcázar, J., Losa‐Reyna, J., Rodríguez-López, C., Navarro‐Cruz, R., Alfaro‐Acha, A., Ara, I., García‐García, F. J., Alegre, L. M., & Guadalupe‐Grau, A. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13494 · Cited by 74
The National Emphysema Treatment Trial (NETT): Part I: Lessons Learned about Emphysema
Criner, G. J., CORDOVA, F. C., Sternberg, A. L., & Martínez, F. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0454ci · Cited by 66
Field Tests of Exercise in COPD: The Six-Minute Walk Test and the Shuttle Walk Test
Brown, C. D., & Wise, R. A. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701480125 · Cited by 77
“This index was then validated in an additional 625 individuals with a wide range of COPD severity (51).”
BackgroundMethodInfluentialMeasuring the effects of COPD on the patient.
Jones, P., Lareau, S., & Mahler, D. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.09.011 · Cited by 73
Shin, T., Oh, Y., Park, J., Lee, K.-S., Oh, S., Kang, D., Sheen, S., Seo, J., Yoo, K., Lee, J., et al. (2015) · Journal of Korean medical science · doi:10.3346/jkms.2015.30.10.1459 · Cited by 58
“Therefore, different findings of our study compared to the other studies can be attributed to the disparity between the cohorts (3, 27, 28).”
ResultKentson, M. U., Tödt, K., Skargren, E. I., Jakobsson, P., Ernerudh, J., Unosson, M., & Theander, K. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816661930 · Cited by 66
Decreased Serum Sirtuin-1 in COPD
Yanagisawa, S., Papaioannou, A. Ι., Papaporfyriou, A., Baker, J. R., Vuppusetty, C., Loukides, S., Barnes, P. J., & Ito, K. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.05.004 · Cited by 73
“This was also confirmed by the fact that s120S was negatively associated with the MRC dyspnea score (Fig 4D) and with the BODE index (Fig 4E), which is known to be a strong predictor of long-term prognosis in COPD.(37) We further analyzed the correlation with all parameters in the GOLD stage 1-2 population only and th…”
ResultPalliative care and prognosis in COPD: a systematic review with a validation cohort
Almagro, P., Yun, S., Sangil, A., Rodríguez‐Carballeira, M., Mariné, M., Landete, P., Soler‐Cataluña, J. J., Soriano, J. B., & Miravitlles, M. (2017) · International Journal of COPD · doi:10.2147/copd.s135657 · Cited by 66
Bertens, L. C. M., Reitsma, J. B., Moons, van Mourik, Broekhuizen, B. D., Hoes, Rütten, & Lammers (2013) · International Journal of COPD · doi:10.2147/copd.s49609 · Cited by 67
“The majority of published prediction models developed for patients with COPD, however, aim to predict mortality, 5–7 and models specifically developed to predict exacerbations are scarce.”
Phenotypic Characteristics Associated With Reduced Short Physical Performance Battery Score in COPD
Patel, M. S., Mohan, D., Andersson, Y. M., Baz, M., Kon, S., Canavan, J. L., Jackson, S. G., Clark, A. L., Hopkinson, N. S., Natanek, S. A., et al. (2013) · CHEST Journal · doi:10.1378/chest.13-1398 · Cited by 65
Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease
Wan, E. S., Cho, M. H., Boutaoui, N., Klanderman, B. J., Sylvia, J. S., Ziniti, J. P., Won, S., Lange, C., Pillai, S. G., Anderson, W. H., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0294oc · Cited by 67
“The body mass index, airway obstruction, dyspnea, and exercise capacity (BODE) index has identified a BMI of less than 21 as a risk factor for increased mortality among patients with COPD (1).”
Self-citationDeterminants of Gait Speed in COPD
Karpman, C., DePew, Z. S., LeBrasseur, N. K., Novotny, P. J., & Benzo, R. P. (2014) · CHEST Journal · doi:10.1378/chest.13-2017 · Cited by 75
Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
Tsimogianni, A. M., Papiris, S. A., Stathopoulos, G. T., Manali, E. D., Roussos, C., & Kotanidou, A. N. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1061-2 · Cited by 68
Chen, H., Wang, Y., Bai, C., & Wang, X. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.01.027 · Cited by 65
“Previous assessments, such as BODE index [18], were found to helpful to monitor and predict the disease in clinic, while those were graded with only limited variables.”
BackgroundMethodMotegi, T., Jones, Ishii, I., Hattori, Kusunoki, Yamada, Gemma, Kida, K., & Furutate, R. (2013) · International Journal of COPD · doi:10.2147/copd.s42769 · Cited by 65
Heffner, J. E. (2013) · Respiratory Care · doi:10.4187/respcare.01831 · Cited by 65
Wewel, A. R., Gellermann, I., Schwertfeger, I., Morfeld, M., MAGNUSSEN, H., & Jörres, R. A. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.08.011 · Cited by 65
Hvidsten, S. C., Storesund, L., Wentzel‐Larsen, T., Gulsvik, A., & Lehmann, S. (2009) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2009.00137.x · Cited by 66
“9 30 (31) 48 (26) >20 42 (43) 100 (54) Socio-economic factors Education 0–11 years 70 (75) 134 (75) 1.”
BackgroundQuality of life measured by the St George's Respiratory Questionnaire and spirometry
Weatherall, M., Marsh, S., Shirtcliffe, P., Williams, M., Travers, J., & Beasley, R. W. (2009) · European Respiratory Journal · doi:10.1183/09031936.00116808 · Cited by 65
“such as quality of life questionnaires and the more recently developed BODE index [22].”
BackgroundKlooster, K., Hartman, J. E., ten Hacken, N. H. T., & Slebos, D. (2016) · Respiration · doi:10.1159/000453529 · Cited by 65
Fan, V. S., Ramsey, S. D., Make, B. J., & Martínez, F. J. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550601169430 · Cited by 69
“A recent study suggests that the multidimensional BODE index, originally developed to predict mortality (18), also predicts COPD hospitalizations (19).”
BackgroundMethodBousquet, J. J., Jørgensen, C., Dauzat, M., Cesario, A., Camuzat, T., Bourret, R., Best, N., Antó, J. M., Abecassis, F., Aubas, P., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140314115505 · Cited by 70
“• Respiratory risk: Many instruments including the BODEindex (Body mass index, Obstruction, Dyspnea, Exercise capacity) [106] and the HADO-score (Health, Activity, Dyspnea, Obstruction) have made the prediction of mortality among COPD patients.”
BackgroundPalliative care services for those with chronic lung disease
Mr, P., Khatri, A., Sutton, L., Welham, S. A., & Ahmedzai, S. H. (2009) · Chronic Respiratory Disease · doi:10.1177/1479972308100538 · Cited by 65
Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease
Hasegawa, W., Yamauchi, Y., Yasunaga, H., Sunohara, M., Jo, T., Matsui, H., Fushimi, K., Takami, K., & Nagase, T. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-151 · Cited by 72
“The mean body mass index (BMI) was 20.1 (SD 3.9) in total, 20.1 (SD 3.8) for males, and 20.1 (SD 4.6) for females.”
BackgroundInfluentialIdentification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
de-Torres, J. P., Marín, J. M., Casanova, C., Pinto-Plata, V., Divo, M. J., Côté, C., Celli, B. R., & Zulueta, J. J. (2015) · CHEST Journal · doi:10.1378/chest.15-1868 · Cited by 64
Self-citationNatural history of COPD: gaps and opportunities
Agustí, A. G. N., & Celli, B. R. (2017) · ERJ Open Research · doi:10.1183/23120541.00117-2017 · Cited by 71
Self-citationRose, L., Istanboulian, L., Carriere, L., Thomas, A., Lee, H.-B., Rezaie, S., Shafai, R., & Fraser, I. (2018) · European Respiratory Journal · doi:10.1183/13993003.01567-2017 · Cited by 75
Spirometric findings as predictors of survival
Lange, P. (2010) · Thorax · doi:10.1136/thx.2010.151274 · Cited by 64
Coughlin, S. R., Liang, W. E., & Parthasarathy, S. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4780 · Cited by 71
Prevalence of COPD in Copenhagen
Fabricius, P. G., Løkke, A., Marott, J. L., Vestbo, J., & Lange, P. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.019 · Cited by 68
“Within recent years it has been acknowledged that COPD is not restricted to the lungs but is accompanied by systemic manifestations with elevated inflammatory markers, weight loss and muscle wasting.31,32 BMI is an important prognostic factor and is included in the BODEindex.17 Thus, our finding that mean BMI was redu…”
InfluentialGückenberger, M., Klement, R. J., Kestin, L. L., Hope, A. J., Belderbos, J. S. A., Werner‐Wasik, M., Yan, D., Sonke, J., Bissonnette, J., Xiao, Y., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.09.016 · Cited by 63
Minas, M., Κostikas, Κ., Papaioannou, A. Ι., Mystridou, P., Karetsi, E., Georgoulias, P., Liakos, N., Pournaras, S., & Gourgoulianis, K. I. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.619600 · Cited by 72
Muscle training with repetitive magnetic stimulation of the quadriceps in severe COPD patients
Bustamante, V., María, E. L. D. S., Gorostiza, A., Jiménez, U., & Gáldiz, J. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.001 · Cited by 69
Budweiser, S., Harlacher, M., Pfeifer, M., & Jörres, R. A. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.836174 · Cited by 63
Śliwiński, P., Górecka, D., Jassem, E., & Pierzchała, W. (2014) · Advances in respiratory medicine · doi:10.5603/piap.2014.0030 · Cited by 81
Camillo, C. A., Langer, D., Osadnik, C. R., Pancini, L., Demeyer, H., Burtin, C., Gosselink, R., Decramer, M., Janssens, W., & Troosters, T. (2016) · International Journal of COPD · doi:10.2147/copd.s113450 · Cited by 65
“26 Importantly, it was identified that improved 6MWD with PR was associated with a significant reduction in mortality in a large set of patients referred to PR.”
BackgroundTelomere shortening and accelerated aging in COPD: findings from the BODE cohort
Córdoba-Lanús, E., Cazorla-Rivero, S., Espinoza-Jiménez, A., de-Torres, J. P., Pajares, M. J., Aguirre‐Jaime, A., Celli, B. R., & Casanova, C. (2017) · Respiratory Research · doi:10.1186/s12931-017-0547-4 · Cited by 63
Self-citationSherrill, D. M., Moy, M. L., Reilly, J. J., & Bonato, P. (2005) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-2-16 · Cited by 62
Co-morbidities and 90-day Outcomes in Hospitalized COPD Exacerbations
Roberts, C. M., Stone, R. A., Lowe, D., Pursey, N. A., & Buckingham, R. J. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.600362 · Cited by 63
“flicting data with both respiratory and non-respiratory causes of death reported (21,22).”
BackgroundDispneia em DPOC: além da escala modified Medical Research Council
Camargo, L. A. C. D. R., & Pereira, C. A. D. C. (2010) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132010000500008 · Cited by 87
Matsumura, T., Mitani, Y., Oki, Y., Fujimoto, Y., Ohira, M., Kaneko, H., Kawashima, T., Nishio, M., & Ishikawa, A. (2015) · Heart & Lung · doi:10.1016/j.hrtlng.2015.08.004 · Cited by 66
Oga, T., Tsukino, Hajiro, Ikeda, & Nishimura (2011) · International Journal of COPD · doi:10.2147/copd.s24420 · Cited by 74
“The BODE index, incorporating measurements of nutrition, airflow limitation, dyspnea, and exercise capacity, has been established for multidimensional staging.(5) It is useful in predicting mortality and hospitalizations and in reflecting disease modification and progression.”
Bhatt, S. P., Kim, Y.-I., Wells, J. M., Bailey, W. C., Ramsdell, J., Foreman, M. G., Jensen, R. L., Stinson, D. S., Wilson, C. G., Lynch, D. A., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201308-251oc · Cited by 67
Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation
Belloli, E. A., Wang, X., Murray, S., Forrester, G., Weyhing, A., Lin, J., Ojo, T., & Lama, V. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0174oc · Cited by 62
“Interestingly, similar to patients with severe obstructive lung disease, a higher proportion of Concurrent group patients also demonstrated significant weight loss at the time of spirometric decline (25, 26).”
ResultDynamic hyperinflation: is it worth measuring?
Calverley, P. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200508-084sf · Cited by 64
Goossens, L. M. A., Leimer, I., Metzdorf, N., Becker, K., & Mölken, M. R. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-163 · Cited by 62
“Consensus has grown that the previous GOLD classification, which was entirely based on forced expiratory volume in 1 second as percentage of the predicted value for someone of the same gender, age and height (FEV1%-predicted), was an insufficiently reliable predictor of the variety of manifestations of the disease [1-…”
BackgroundFactors Associated with Depression in COPD: A Multicenter Study
Martínez‐Rivera, C., Costán, J., Navarrete, B. A., García-Polo, C., Iturriaga, L. A. R., Herrejón, A., Ros, J. A., García-Sidro, P., Tirado-Conde, G., López-Campos, J. L., et al. (2016) · Lung · doi:10.1007/s00408-016-9862-7 · Cited by 62
Pichon, R., Couturaud, F., Mialon, P., Ber-Moy, C. L., Péran, L., Lochon, C., Nowak, E., & Beaumont, M. (2016) · Respiration · doi:10.1159/000446517 · Cited by 62
Blasio, F. D., Santaniello, M., Blasio, F. D., Mazzarella, G., Bianco, A., Lionetti, L., Franssen, F. M. E., & Scalfi, L. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.147 · Cited by 66
Hansen, H., Beyer, N., Frølich, A., Godtfredsen, N. S., & Bieler, T. (2018) · International Journal of COPD · doi:10.2147/copd.s174248 · Cited by 64
Pomiès, P., Rodriguez, J., Blaquière, M., Sedraoui, S., Gouzi, F., Carnac, G., Laoudj‐Chenivesse, D., Mercier, J., Préfaut, C., & Hayot, M. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12390 · Cited by 61
“The BODE index takes into account the body mass index, the airflow obstruction, the functional dyspnoea and the exercise capacity [22].”
BackgroundAgustí, A. G. N., & Sin, D. D. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.09.006 · Cited by 68
Laviolette, L., Lands, L. C., Dauletbaev, N., Saey, D., Milot, J., Provencher, S., LeBlanc, P., & Maltais, F. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0142 · Cited by 61
On ethical locations: The good death in Thailand, where ethics sit in places
Stonington, S. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.045 · Cited by 69
“, 2007); for chronic obstructive pulmonary disease, I used FEV1 < 20% predicted or BODE score > 8 (Celli et al., 2004); for renal disease, I used any candidate for dialysis or receiving dialysis, or with a glomerular filtration rate < 20; for liver failure, I usedMELD score> 27 (Kamath & Kim, 2007) or ChildPugh stage…”
MethodThe concept of control of COPD in clinical practice
Miravitlles, M., Soler‐Cataluña, J. J., & Navarrete, B. A. (2014) · International Journal of COPD · doi:10.2147/copd.s71370 · Cited by 61
“While severity assesses the future risk of death and other complications, 7–9 clinical impact refers to the current repercussion the disease has on the patient.”
Zhou, Y., Wang, D., Liu, S., Lü, J., Zheng, J., Zhong, N., & Ran, P. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.781579 · Cited by 61
Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD
Holverda, S., Rietema, H., Bogaard, H. J., Westerhof, N., Postmus, P. E., Boonstra, A., & Noordegraaf, A. V. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.01.012 · Cited by 62
“A reduced exercise capacity is one of the main symptoms in chronic obstructive pulmonary disease (COPD), with important impact on quality of life and a strong relation with mortality [1,2].”
BackgroundCharacteristics and self-rated health of overlap syndrome
Lee, J. H., Chung, J. W., Kong, K. A., Lee, S. J., Ryu, Y. J., & Chang, J. H. (2014) · International Journal of COPD · doi:10.2147/copd.s61093 · Cited by 69
“001 Metabolic syndrome*** 1,639 1,312 (25) 148 (34) 128 (32) 51 (39) ,0.”
Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
Lee, S. J., Boscardin, W. J., Kirby, K. A., & Covinsky, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108540 · Cited by 61
“For example, many mortality prediction indexes have been developed to predict x-year mortality risk for general populations [8] as well as for patients with a dominant condition such as breast cancer, heart failure or obstructive lung disease [27–29].”
BackgroundCelli, B. R. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-029ms · Cited by 61
Self-citationYang, L., Zhou, M., Smith, M. C., Yang, G., Peto, R., Wang, J., Boreham, J., Hu, Y., & Chen, Z. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq051 · Cited by 70
Durheim, M. T., Smith, P. J., Babyak, M. A., Mabe, S. K., Martinu, T., Welty-Wolf, K. E., Emery, C. F., Palmer, S. M., & Blumenthal, J. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-365oc · Cited by 60
Rio, F. G., Soriano, J. B., Miravitlles, M., Muñoz, L., Duran‐Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2010) · CHEST Journal · doi:10.1378/chest.10-1721 · Cited by 61
Success in Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
Scott, A. S., Baltzan, M., Fox, J. M., & Wolkove, N. (2010) · Canadian Respiratory Journal · doi:10.1155/2010/203236 · Cited by 61
Caracterización fenotípica y evolución de la EPOC en el estudio PAC-COPD: diseño y metodología
García‐Aymerich, J., Gómez, F. P., & Antó, J. M. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2008.03.001 · Cited by 61
Baldi, S. (2010) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s7739 · Cited by 61
Sørensen, A. K., Holmgaard, D. B., Mygind, L. H., Johansen, J. S., & Pedersen, C. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0064-5 · Cited by 63
“low body mass index (BMI), low forced expiratory volume in 1 second (FEV1), level of dyspnea and exercise capacity, into an index which is associated with increased risk of mortality [4].”
BackgroundContrast enhanced CT-scans are not comparable to non-enhanced scans in emphysema quantification
Heußel, C. P., Kappes, J., Hantusch, R., Hartlieb, S., Weinheimer, O., Kauczor, H., & Eberhardt, R. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.03.023 · Cited by 61
“of the patient [3].”
BackgroundDisease severity and symptoms among patients receiving monotherapy for COPD
Dransfield, M. T., Bailey, W. C., Crater, G., Emmett, A. H., O’Dell, D. M., & Yawn, B. P. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00059 · Cited by 60
Improving physical activity in patients with COPD with urban walking circuits
Pleguezuelos, E., Pérez, M. E., Guirao, L., Samitier, B., Ortega, P., Vilà, X., Solans, M., Riera, A., Moreno, E., Merí, Á., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.07.008 · Cited by 63
“The BODE index (Body mass index, Obstruction, Dyspnea and Exercise) was calculated for all the participants as previously described by the authors [19].”
MethodChronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions
Fragoso, C. A. V., Concato, J., McAvay, G., Ness, P. H. V., Rochester, C. L., Yaggi, H. K., & Gill, T. M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.030 · Cited by 63
“The five most common self-reported chronic conditions were hypertension, arthritis, diabetes mellitus, myocardial infarction, and COPD.”
BackgroundInfluentialAustin, P. C., Stanbrook, M. B., Anderson, G. M., Newman, A. M., & Gershon, A. S. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.09.011 · Cited by 67
Could “red cell distribution width” predict COPD severity?
Tertemiz, K. C., Alpaydın, A. Ö., Sevinç, C., Ellıdokuz, H., Acara, A. Ç., & Cimrin, A. H. (2016) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2015.11.006 · Cited by 60
“BODE index was calculated according to body mass index (BMI), FEV1, 6MWT, modified medical research council dyspnea scale (MMRC) at the time of diagnosis.(14)”
MethodCoultas, D., Jackson, B. E., Russo, R., PEOPLES, J. A., Singh, K. P., Sloan, J., Uhm, M., Ashmore, J. A., Blair, S. N., & Bae, S. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201704-308oc · Cited by 60
Transbronchoscopic Pulmonary Emphysema Treatment
de Oliveira, H. G., de Macedo-Neto, A. V., John, Â. B., Jungblut, S., Prolla, J. C., Menna‐Barreto, S. S., & Fortis, E. A. F. (2006) · CHEST Journal · doi:10.1378/chest.130.1.190 · Cited by 60
Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism
Celli, B. R. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200510-111jh · Cited by 71
“It has a long subclinical phase but once symptoms develop, COPD usually follows a course of progressive dyspnea at ever lower levels of exercise, gas exchange imbalance, and respiratory failure (1, 3). In the end, death can occur either from the respiratory failure or from the frequently associated comorbidity such as…”
BackgroundSelf-citationNew Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
Spruit, M. A., & Wouters, E. F. �. (2007) · Sports Medicine · doi:10.2165/00007256-200737060-00004 · Cited by 62
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
Hanlon, P., Lewsey, J., Quint, J. K., Jani, B., Nicholl, B. I., McAllister, D., & Mair, F. S. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001314 · Cited by 63
Benzo, R. P., Kirsch, J. L., Dulohery, M. M., & Abascal-Bolado, B. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-490oc · Cited by 65
A predictive model of hospitalisation and death from chronic obstructive pulmonary disease
Schembri, S., Anderson, W. J., Morant, S. V., Winter, J., Thompson, P., Pettitt, D., MacDonald, T. M., & Winter, J. H. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.04.021 · Cited by 59
Faganello, M. M., Tanni, S. É., Pelegrino, N. R. G., Lucheta, P. A., Godoy, I., & Sanchez, F. F. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181bb8111 · Cited by 69
Tsai, C., Clark, S., Cydulka, R. K., Rowe, B. H., & Camargo, C. A. (2006) · Academic Emergency Medicine · doi:10.1197/j.aem.2006.07.034 · Cited by 63
“Has primary care provider 217 (93) 130 (86) 0.02 ED is usual site for problem COPD care 102 (45) 94 (64) 22 ) 22 ) 11 (7) <0.001 Congestive heart failure 34 (15) 13 (9) 0.08 Newly occurring arrhythmia 4 (2) 0 (0) 0.1 Pneumothorax”
InfluentialOliveira, C. C., Lee, A. L., Granger, C. L., Miller, K. J., Irving, L. B., & Denehy, L. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.04.012 · Cited by 69
Díaz, A. A., Morales, A., Díaz, J. C., Ramos, C., Klaassen, J., Fernando Saldías, P., Aravena, C., Díaz, R., Lisboa, C., Washko, G. R., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.011 · Cited by 63
Tuppin, M. P., Paratz, J. D., Chang, A. T., Seale, H. E., Walsh, J., Kermeen, F. D., McNeil, K., & Hopkins, P. M.-A. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.03.017 · Cited by 67
Qiu, Z. (2015) · Medical Science Monitor · doi:10.12659/msm.892769 · Cited by 61
“The BODE index has been validated in COPD patients, and is responsive to PR [26].”
MethodLari, S. M. (2010) · International Journal of COPD · doi:10.2147/copd.s12545 · Cited by 62
“The BODE (body mass index, obstruction, dyspnea, and exercise capacity) index was calculated in all patients with total possible values in the range 0–10.(24) Dyspnea was evaluated by the Modified Medical Research Council scale,(24) which was graded between 0–4 according to the patient’s complaint.”
Mair, G., Miller, J., McAllister, D., Maclay, J. D., Connell, M., Murchison, J. T., & MacNee, W. (2008) · European Respiratory Journal · doi:10.1183/09031936.00111808 · Cited by 59
White, P. T., White, S., Edmonds, P. M., Gysels, M., Moxham, J., Seed, P. T., & Shipman, C. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x578043 · Cited by 59
Fatigue in COPD: association with functional status and hospitalisations
Paddison, J. S., Effing, T., Quinn, S. J., & Frith, P. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00021412 · Cited by 65
“disablement due to dyspnoea, and exercise capacity [9].”
A simple score for assessing stable chronic obstructive pulmonary disease
Esteban, C., Quintana, J. M., Aburto, M., Moraza, J., & Capelastegui, A. (2006) · QJM · doi:10.1093/qjmed/hcl110 · Cited by 59
Golpe, R., Pérez‐de‐Llano, L. A., Marote, L. M., & Racamonde, A. V. (2013) · Respiratory Care · doi:10.4187/respcare.02290 · Cited by 59
Güell, M. R., Lobato, S. D., Trigo, G. R., Vélez, F. M., Miguel-Pagola, M. S., Cejudo, P., Ruiz, F. Ó., Muñoz, A., Iturri, J. B. G., García, A., et al. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.02.014 · Cited by 92
A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria
Dilektaşlı, A. G., Pórszász, J., Casaburi, R. H., Stringer, W. W., Bhatt, S. P., Pak, Y., Rossiter, H. B., Washko, G. R., Castaldi, P. J., Estépar, R. S. J., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.06.047 · Cited by 64
“1 Smoking history, pack-y 36 (24-48) 45 (34-65) 35 (23-48) 45 (33-65)”
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.